-
Inovio Pharmaceuticals, Inc. is an
American biotechnology company focused on the discovery, development, and
commercialization of
synthetic DNA products...
-
Inovio COVID-19
vaccine is a COVID-19
vaccine candidate developed by
Inovio Pharmaceuticals. In
February 2020
after receiving details of the
genetic sequence...
-
government research funding were:
Indirectly funded companies include:
Inovio As of
October 2020,
Operation Warp
Speed had
spent less than $1 billion...
-
antibody therapies: In
October 2018, the
foundation awarded $8,279,723 to
Inovio Pharmaceuticals to fund the
development of "next-generation"
delivery methods...
-
exclusive rights to
Inovio Pharmaceuticals' INO-3112
immunotherapy under an
agreement which could net more than US$727.5
million for
Inovio. INO-3112 targets...
- 1517/14712590903379502. PMID 20088713. S2CID 2700243. "Hepatitis C
vaccine by
Inovio could be
tested in
humans by end of year".
Philadelphia Business Journal...
- for SARS-CoV-2, being: Moderna,
Inovio Pharmaceuticals, and the
University of
Queensland (UQ). By
February 2020,
Inovio announced that it had produced...
- away'". BBC News.
Retrieved 28
January 2016.
Sagonowsky E (21 June 2016). "
Inovio set for
first Zika
vaccine human trial". fiercepharma.com.
Retrieved 1 July...
- 2020.
Retrieved 14 July 2020. "IVI,
INOVIO, and KNIH to
partner with CEPI in a
Phase I/II
clinical trial of
INOVIO's COVID‑19 DNA
vaccine in
South Korea"...
- Zika
virus began testing at the
National Institutes of Health. Separately,
Inovio Pharmaceuticals and
GeneOne Life
Science began tests of a
different DNA...
